Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 2002

View Archived Issues

SkyePharma and GeneMedix to develop extended-release interferon alfa-2b

Texas Biotechnology presents mid-year update

Xenical improves weight loss and glycemic control in type 2 diabetes patients on metformin

VaxGen and Genentech revise AIDS vaccine candidate agreement

Inhibitors of ubiquitin ligases as potential new anticancer agents

Antisoma's vascular targeting agent well tolerated in phase I trials

Heat-activated drug therapy for prostate cancer enters clinical trials

U.K. introduction for Amgen's novel rheumatoid arthritis therapeutic

Buprenorphine matrix patch for chronic pain relief launched in U.K.

Biochemical profile of SM-13496, an atypical antipsychotic, characterized in vitro and in vivo

Antipsychotic effects demonstrated in patients for dopamine stabilizer OSU-6162

Preclinical profile of Lu-35-138 described at CINP congress

New data on the efficacy and safety of the antidepressant S-20098

FDA approval for Remicade for remission maintenance of Crohn's disease

Gleevec submitted in U.S. and E.U. for first-line use in CML

E.U. approval for Zenapax in pediatric renal transplantation

Schering AG acquires distribution rights for Testogel in Europe

Reolysin enters phase I/II in brain cancer

Adenylyl cyclase inhibitors and their use in congestive heart failure

Novel PPARalpha agonists in Lilly pipeline

New antibacterial carbapenems in early development at Sankyo

GSK claims tachykinin NK2/NK3 antagonists for respiratory disorders

Bombesin receptor antagonists with potential in sexual dysfunction

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...